Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm-Reference-Cited by-同舟云学术

Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm

Published:2020-10-05 Issue:12 Volume:18 Page:3359-3370
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Castiglione Melissa¹,Jiang Ya‐Ping²,Mazzeo Christopher³,Lee Sandy⁴,Chen Juei‐Suei¹,Kaushansky Kenneth⁵,Yin Wei⁶,Lin Richard Z.²⁷,Zheng Haoyi⁸^ORCID,Zhan Huichun¹⁷

Affiliation:

1. Department of Medicine Stony Brook School of Medicine Stony Brook NY USA

2. Department of Physiology and Biophysics Institute of Molecular Cardiology Stony Brook University Stony Brook NY USA

3. Stony Brook School of Medicine Stony Brook NY USA

4. Department of Molecular and Cellular Pharmacology Stony Brook University Stony Brook NY USA

5. Office of the Sr. Vice President Health Sciences Stony Brook Medicine Stony Brook NY USA

6. Department of Biomedical Engineering Stony Brook University Stony Brook NY USA

7. Medical Service Northport VA Medical Center Northport NY USA

8. Cardiac Imaging The Heart Center Saint Francis Hospital Roslyn NY USA

Funder

U.S. Department of Veterans Affairs

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15095

Reference78 articles.

1. Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation

2. Functional interdependence of hematopoietic stem cells and their niche in oncogene promotion of myeloproliferative neoplasms: the 159th biomedical version of “it takes two to tango”

4. Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding Endothelial MPL and JAK2V617F Mutation: Insight Into Cardiovascular Dysfunction in Myeloproliferative Neoplasms;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-09

2. Anticoagulation for splanchnic vein thrombosis in myeloproliferative neoplasms: a systematic review and meta-analysis;Journal of Thrombosis and Haemostasis;2024-08

3. Prediction of acute coronary syndrome in patients with myeloproliferative neoplasms;Frontiers in Cardiovascular Medicine;2024-06-25

4. Portal Vein Thrombosis: State-of-the-Art Review;Journal of Clinical Medicine;2024-03-06

5. Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms’;Current Research in Translational Medicine;2024-03